In vitro activities of the des-fluoro(6) Quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections
- PMID: 11850275
- PMCID: PMC127469
- DOI: 10.1128/AAC.46.3.866-870.2002
In vitro activities of the des-fluoro(6) Quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections
Abstract
BMS-284756, a new des-fluoro(6) quinolone, was very active against 240 aerobic and 180 anaerobic isolates from bite victims. It inhibited 403 of 420 (96%) isolates, including those of Moraxella spp., CDC group EF-4, and Eikenella corrodens at < or = 2 microg/ml and those of all Pasteurella spp. and Bergeyella zoohelcum at < or = 0.015 microg/ml. Fusobacterium russii and 6 of 11 Fusobacterium nucleatum isolates of animal bite origin were resistant, but isolates of human bite origin were susceptible, which suggests that they were of a different subspecies.
Similar articles
-
Activity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infections.Antimicrob Agents Chemother. 1999 Jun;43(6):1475-9. doi: 10.1128/AAC.43.6.1475. Antimicrob Agents Chemother. 1999. PMID: 10348774 Free PMC article.
-
Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections.Antimicrob Agents Chemother. 2000 Sep;44(9):2525-9. doi: 10.1128/AAC.44.9.2525-2529.2000. Antimicrob Agents Chemother. 2000. PMID: 10952607 Free PMC article.
-
Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogens.Antimicrob Agents Chemother. 2000 Oct;44(10):2747-51. doi: 10.1128/AAC.44.10.2747-2751.2000. Antimicrob Agents Chemother. 2000. PMID: 10991855 Free PMC article.
-
Role of anaerobic bacteria in bite-wound infections.Rev Infect Dis. 1984 Mar-Apr;6 Suppl 1:S177-83. doi: 10.1093/clinids/6.supplement_1.s177. Rev Infect Dis. 1984. PMID: 6372026 Review.
-
[Bite wound infections].Tidsskr Nor Laegeforen. 2004 Dec 16;124(24):3194-6. Tidsskr Nor Laegeforen. 2004. PMID: 15608763 Review. Norwegian.
Cited by
-
Postoperative care of the facial laceration.Craniomaxillofac Trauma Reconstr. 2010 Dec;3(4):189-200. doi: 10.1055/s-0030-1268516. Craniomaxillofac Trauma Reconstr. 2010. PMID: 22132257 Free PMC article.
-
In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.Antimicrob Agents Chemother. 2003 Nov;47(11):3667-71. doi: 10.1128/AAC.47.11.3667-3671.2003. Antimicrob Agents Chemother. 2003. PMID: 14576144 Free PMC article.
-
In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species.Antimicrob Agents Chemother. 2002 Sep;46(9):3068-70. doi: 10.1128/AAC.46.9.3068-3070.2002. Antimicrob Agents Chemother. 2002. PMID: 12183274 Free PMC article.
-
New drugs to treat skin and soft tissue infections.Curr Infect Dis Rep. 2007 Sep;9(5):408-14. doi: 10.1007/s11908-007-0063-7. Curr Infect Dis Rep. 2007. PMID: 17880852
-
Time-kill studies of the antianaerobe activity of garenoxacin compared with those of nine other agents.Antimicrob Agents Chemother. 2003 Apr;47(4):1399-402. doi: 10.1128/AAC.47.4.1399-1402.2003. Antimicrob Agents Chemother. 2003. PMID: 12654677 Free PMC article.
References
-
- Chambers, H. F., and H. C. Neu. 1995. Penicillins, p. 233-245. In G. L. Mandel, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 4th ed. Churchill Livingstone Inc., New York, N.Y.
-
- Goldstein, E. J. C. 1992. Bite wounds and infection. Clin. Infect. Dis. 14:633-640. - PubMed
-
- Goldstein, E. J. C. 1998. New horizons in the bacteriology, antimicrobial susceptibility and therapy of animal bite wounds. J. Med. Microbiol. 47:1-3. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous